State of Wyoming’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-22,674
Closed -$179K – 1878
2026
Q1
$179K Buy
22,674
+8,287
+58% +$134K 0.02% 1015
2025
Q4
$248K Buy
14,387
+5,663
+65% +$110K 0.03% 819
2025
Q3
$225K Buy
8,724
+1,986
+29% +$75K 0.03% 865
2025
Q2
$387K Buy
6,738
+1,598
+31% +$128K 0.05% 461
2025
Q1
$556K Buy
5,140
+240
+5% +$20.9K 0.07% 189
2024
Q4
$233K Buy
4,900
+2,312
+89% +$140K 0.03% 733
2024
Q3
$254K Buy
2,588
+1,749
+208% +$226K 0.04% 544
2024
Q2
$137K Buy
839
+300
+56% +$42.7K 0.02% 833
2024
Q1
$82.2K Buy
+539
New +$89.7K 0.01% 1121
2022
Q1
– Sell
-29
Closed -$20K – 1772
2021
Q4
$20K Buy
+29
New +$17.6K 0.01% 1462

Other funds holding AGL

State of Wyoming's AGL Position: Q2 2026 in Review

State of Wyoming sold out of Agilon Health (AGL) in Q2 2026, closing a stake of 22,674 shares — an estimated $179K sold.

State of Wyoming first reported a position in AGL in Q4 2021 and held it in 10 quarters. The position peaked at $556K in Q1 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • State of Wyoming reported no remaining Agilon Health position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 22,674 Agilon Health shares in Q2 2026, an estimated $179K.
  • State of Wyoming first reported a position in Agilon Health in Q4 2021 and held it in 10 quarters.
  • State of Wyoming's Agilon Health position peaked at $556K in Q1 2025.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.